cNeuro cDAT enables visual evaluation and quantification of 123 Ioflupane (DaTSCAN) images. The software enables automated quantification of tracer uptake and comparison with the corresponding tracer uptake in healthy subjects as provided by normal population databases of 123 Ioflupane (DaTSCAN) images. cNeuro cDAT assists in detection of loss of functional dopaminergic neuron terminals in the striatum. cNeuro cDAT has not been demonstrated to improve 123 Ioflupane reader performance for distinguishing positive from negative patients. cDAT is a module on the cNeuro Suite platform which provides common functionality and infrastructure. cNeuro Suite allows users to login to the system, to access and modify system data (organization, user and study data) and launch the medical device products of Combinostics (cNeuro cMRI, cNeuro cDSI, cNeuro cPET, and cNeuro cDAT). These end user applications share common functionality and infrastructure such as user authentication, study management and selection, study data storage, etc. The common functionality is provided by cNeuro Suite component. There is also a need to facilitate data transfers with hospital information systems on customers’ premises. These are implemented within a stand-alone data transfer utility component called cNeuro Gateway, which connects with cNeuro Suite.